Independent fund research. Built on SEC filings.

How we research funds

Mutual fund · Global Stock · New York Life Investments

NYLI Epoch Global Equity Yield Fund Class C (EPSKX)

Ticker EPSKX · Since 2009-11-16 · · Holdings as of Jul 31, 2026

Expense ratio
1.84%$184/yr per $10k
5-yr return
+10.9%annualized
1-yr return
+19.9%as of Dec 2025
Net assets
$996.7Mall share classes
Holdings
126

Bottom line

Is EPSKX a good fund? The bottom line

EPSKX is the Class C share class of NYLI Epoch Global Equity Yield Fund, an actively managed global stock mutual fund from New York Life Investments.

Its expense ratio is 1.84% — about $184 a year on every $10,000 invested, more expensive than 91% of global stock funds we track.

It returned +19.9% over one year, +10.9% a year over five years, +8.0% a year over ten (as of Dec 31, 2025, per its prospectus).

With $997 million in net assets and 126 holdings, its largest position is Hewlett Packard Enterprise Co. (2.3%) and the top 10 make up 20.4% of the portfolio.

What stands out

  • 5-year return beat 79% of category peers
  • No front-end sales load

What to watch

  • Expensive for its category (1.84%)
  • 12b-1 marketing fee of 1% a year

Updated Nov 19, 2026

What EPSKX invests in

The Fund seeks a high level of income. Capital appreciation is a secondary investment objective.

"The Fund generally invests in a diversified portfolio consisting of equity securities of companies located throughout the world, including the United States, that have a history of attractive dividend yields and positive growth in operating cash flow. Equity or equity-related securities represent an ownership interest, or the right to acquire an ownership interest, in an issuer. Under normal circumstances, the Fund invests at least 80% of its assets (net assets plus any borrowings for investment purposes) in equity securities of dividend-paying companies across all market capitalizations. Equity securities include common stocks and depositary receipts. The Fund may invest up to 20% of its net assets in securities issued by companies in emerging markets, as determined by the Fund's Subadvisor, Epoch Investment Partners, Inc., when it believes those securities represent attractive…

From the fund's prospectus (filed Feb 26, 2026).

EPSKX performance

Average annual total returns
1 yr5 yr10 yr
EPSKX+19.9%+10.9%+8.0%
Global Stock median+15.2%+7.6%+9.5%

Source: Fund prospectus, as of Dec 31, 2025

Full EPSKX performance history →

What EPSKX costs

On a $10,000 investment, EPSKX's 1.84% expense ratio costs about $184 a year. The prospectus estimates $2,042 in total costs over 10 years (assuming 5% annual returns). The median global stock fund charges 0.95%.

See the full EPSKX fee table →

EPSKX top 10 holdings

#Holding% of fund
1Hewlett Packard Enterprise Co.2.34%
2Microsoft Corp.2.30%
3Cisco Systems, Inc.2.24%
4Dell Technologies, Inc.2.15%
5CVS Health Corp.2.12%
6Taiwan Semiconductor Manufacturing Co. Ltd.2.11%
7Broadcom, Inc.2.07%
8Texas Instruments, Inc.1.86%
9Analog Devices, Inc.1.84%
10Manulife Financial Corp.1.40%

Source: SEC Form N-PORT, period ended Jul 31, 2026

The top 10 make up 20.4% of the fund. See all top 25 holdings and asset mix →

Alternatives to EPSKX

More funds like EPSKX →

EPSKX FAQ

What is the expense ratio of EPSKX?
EPSKX's expense ratio is 1.84%, which works out to about $184 a year for every $10,000 invested. The prospectus estimates total costs of $2,042 over 10 years on a $10,000 investment (assuming 5% annual returns).
Is EPSKX a good investment?
It depends on your goals, but the data points to: 5-year return beat 79% of category peers; no front-end sales load; expensive for its category (1.84%); 12b-1 marketing fee of 1% a year. This is general information, not personalized advice.
What does EPSKX hold?
EPSKX's largest holdings are Hewlett Packard Enterprise Co. (2.3%), Microsoft Corp. (2.3%), Cisco Systems, Inc. (2.2%), Dell Technologies, Inc. (2.2%), CVS Health Corp. (2.1%). It holds 126 positions in total as of Jul 31, 2026 (SEC Form N-PORT).
What is EPSKX's 5-year return?
EPSKX returned +10.9% a year over the five years ending Dec 31, 2025, and +8.0% a year over ten years. Past performance does not guarantee future results.
Does EPSKX have a sales load?
No. EPSKX has no front-end sales charge. It may charge a deferred sales charge of up to 1% if sold early.
Who manages EPSKX?
EPSKX is offered by New York Life Investments through New York Life Investments Funds Trust.